Mucoepidermoid carcinoma other imaging findings

Mucoepidermoid carcinoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Mucoepidermoid Carcinoma from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Mucoepidermoid carcinoma other imaging findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Mucoepidermoid carcinoma other imaging findings All Images X-rays Echo and Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Mucoepidermoid carcinoma other imaging findings
CDC on Mucoepidermoid carcinoma other imaging findings
Mucoepidermoid carcinoma other imaging findings in the news
Blogs on Mucoepidermoid carcinoma other imaging findings
Directions to Hospitals Treating Mucoepidermoid carcinoma
Risk calculators and risk factors for Mucoepidermoid carcinoma other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: {Badria Munir M.B.B.S.[2] , Maria Fernanda Villarreal, M.D. [3]

Overview

FDG-PET scan can be ued to plan ahead of treatment of mucoepidermoid carcinoma. It also detects metastatic lesions.

Other Imaging Findings

• FDG-PET scanning can be used to plan treatment of salivary gland malignancies by detecting lymph node metastases. This is particularly useful when used in addition to CT scanning.

• Technetium-99m (Tc-99m) pertechnetate scintigraphy can also be used to diagnose warthin tumors with correlation between tumor size and Tc-99m uptake.